{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:18:20Z","timestamp":1789075100340,"version":"build-2803163510"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Samjin Pharmaceutical Co.","award":["202307350001"],"award-info":[{"award-number":["202307350001"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea grant funded by the Korean Government","doi-asserted-by":"publisher","award":["RS-2023-00280552"],"award-info":[{"award-number":["RS-2023-00280552"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Cyproheptadine-based appetite stimulants (CAS) have been safely used in Korea for over 30 years. However, in older adults who are vulnerable to malnutrition, sarcopenia, and fall-related morbidity, safety of CAS in nutrition care remains uncertain due to limited evidence and its antihistaminic effects. This study aimed to assess the real-world safety of CAS compared with megestrol and other antihistamines to inform safe pharmacologic support within clinical nutrition practice. Methods: A retrospective observational study was conducted using Seoul National University Hospital\u2019s common data model. Patients who were prescribed CAS, megestrol, or antihistamines between 2004 and 2022 were enrolled. To balance covariates, propensity score matching was applied. The primary outcomes\u2014dizziness, sedation, and hypotension\u2014were evaluated within 30 days of drug administration. Additionally, sensitivity analyses and subgroup assessments by age and duration of use were performed to evaluate robustness of the findings. Results: No significant differences were observed in the risk of dizziness, sedation, or hypotension when CAS was compared to megestrol, with adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of 1.02 (0.70\u20131.50) for dizziness, 0.53 (0.19\u20131.54) for sedation, and 0.70 (0.34\u20131.44) for hypotension. Similar findings were noted in the comparison with antihistamines, where the aHRs for dizziness, sedation, or hypotension of 0.56 (0.41\u20130.78), 1.05 (0.46\u20132.38), and 0.65 (0.36\u20131.17), respectively. Conclusions: CAS demonstrated an acceptable safety profile in older adults, with safety comparable to both megestrol and antihistamines.<\/jats:p>","DOI":"10.3390\/jcm15010054","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:27:47Z","timestamp":1766500067000},"page":"54","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Safety of Cyproheptadine-Based Appetite Stimulants: An Electronic Health Record-Based Retrospective Cohort Study in Adult Patients"],"prefix":"10.3390","volume":"15","author":[{"given":"Minoh","family":"Ko","sequence":"first","affiliation":[{"name":"College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Clinical Bioinformatics, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeman","family":"Jang","sequence":"additional","affiliation":[{"name":"Samjin Pharmaceutical Co., Ltd., Seoul 04054, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soomin","family":"Lee","sequence":"additional","affiliation":[{"name":"Samjin Pharmaceutical Co., Ltd., Seoul 04054, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumkyu","family":"Shin","sequence":"additional","affiliation":[{"name":"Samjin Pharmaceutical Co., Ltd., Seoul 04054, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belong","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 07061, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dankook University, Cheonan 31116, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Young","family":"Jang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Gachon University, Incheon 13120, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Norman, K., Ha\u00df, U., and Pirlich, M. (2021). Malnutrition in Older Adults-Recent Advances and Remaining Challenges. Nutrients, 13.","DOI":"10.3390\/nu13082764"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cger.2017.02.004","article-title":"Anorexia of Aging: Assessment and Management","volume":"33","author":"Landi","year":"2017","journal-title":"Clin. Geriatr. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2019.05.006","article-title":"Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults \u2265 65 years: A systematic review and meta-analysis","volume":"126","author":"Verwijs","year":"2019","journal-title":"Maturitas"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(82)92422-9","article-title":"Cyproheptadine for anorexia nervosa","volume":"1","author":"Halmi","year":"1982","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.appet.2019.02.012","article-title":"Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review","volume":"137","author":"Harrison","year":"2019","journal-title":"Appetite"},{"key":"ref_6","unstructured":"(2024, November 05). DailyMed Cyproheptadine Hydrochloride\u2014Drug Information, U.S. National Library of Medicine, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=80e13d3f-f4db-4bb4-95d5-5ac1afa70e7e."},{"key":"ref_7","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) (2025, September 12). Cyproheptadine Cinfa 4 mg Comprimidos: Prospecto. CIMA: Centro de Informaci\u00f3n Online de Medicamentos. Available online: https:\/\/cima.aemps.es\/cima\/dochtml\/p\/35622\/Prospecto_35622.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.clinthera.2021.08.001","article-title":"Efficacy and tolerability of cyproheptadine in poor appetite: A multicenter, randomized, double-blind, placebo-controlled study","volume":"43","author":"Kim","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_9","first-page":"CD004310","article-title":"Megestrol acetate for treatment of anorexia\u2013cachexia syndrome","volume":"2013","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ncp.10839","article-title":"A review of the efficacy of appetite-stimulating medications in hospitalized adults","volume":"38","author":"Steiner","year":"2023","journal-title":"Nutr. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e41030","DOI":"10.2196\/41030","article-title":"Chronic disease prediction using the common data model: Development study","volume":"1","author":"Lee","year":"2022","journal-title":"JMIR AI"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pds.5232","article-title":"Greedy caliper propensity score matching can yield variable estimates of the treatment\u2013outcome association: A simulation study","volume":"30","author":"Komen","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1475-6773.2004.00289.x","article-title":"Potentially inappropriate medication prescriptions among elderly nursing home residents: Their scope and associated resident and facility characteristics","volume":"39","author":"Lau","year":"2004","journal-title":"Health Serv. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11096-013-9793-9","article-title":"Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia","volume":"35","author":"Lee","year":"2013","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_17","unstructured":"Tisdale, J.E. (2025, September 12). Cyproheptadine: Drug Information. UpToDate. Available online: https:\/\/www-uptodate-com.libproxy.dcmc.co.kr\/contents\/cyproheptadine-drug-information?search=cyproheptadine&source=panel_search_result&selectedTitle=1~45&usage_type=panel&kp_tab=drug_general&display_rank=1#F155687."},{"key":"ref_18","unstructured":"Simons, F.E.R. (1996). Histamine receptors: Specific ligands, receptor biochemistry, and signal transduction. Histamine and H1-Receptor Antagonists in Allergic Disease, Marcel Dekker."},{"key":"ref_19","first-page":"6299","article-title":"Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients","volume":"30","author":"Burger","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaad.2021.01.027","article-title":"Antihistamine safety in older adult dermatologic patients","volume":"87","author":"Grinnell","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00002512-200522040-00002","article-title":"Pharmacological management of allergic rhinitis in the elderly: Safety issues with oral antihistamines","volume":"22","author":"Hansen","year":"2005","journal-title":"Drugs Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1060028018802816","article-title":"Efficacy and safety of appetite-stimulating medications in the inpatient setting","volume":"53","author":"Howard","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00044011-199816060-00001","article-title":"Efficacy and tolerability comparison of ebastine 10 and 20 mg with loratadine 10 mg: A double-blind, randomised study in patients with perennial allergic rhinitis","volume":"16","author":"Davies","year":"1998","journal-title":"Clin. Drug Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200222002-00001","article-title":"Pharmacology of desloratadine: Special characteristics","volume":"22","author":"DuBuske","year":"2002","journal-title":"Clin. Drug Investig."},{"key":"ref_25","first-page":"465","article-title":"H1-antihistamines in the elderly","volume":"17","author":"Kaliner","year":"2002","journal-title":"Histamine and H1-Antihistamines in Allergic Disease"},{"key":"ref_26","first-page":"S1","article-title":"Levocetirizine bei allergischen Erkrankungen","volume":"25","author":"Klimek","year":"2002","journal-title":"Allergologie"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.320.7243.1184","article-title":"Sedation with \u201cnon-sedating\u201d antihistamines: Four prescription-event monitoring studies in general practice","volume":"320","author":"Mann","year":"2000","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archfami.5.8.464","article-title":"Safety of antihistamines in the treatment of allergic rhinitis in elderly patients","volume":"5","author":"McCue","year":"1996","journal-title":"Arch. Fam. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/CIA.S325008","article-title":"Anorexia of aging: Metabolic changes and biomarker discovery","volume":"17","author":"Picca","year":"2022","journal-title":"Clin. Interv. Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0091-6749(99)70120-X","article-title":"The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis","volume":"104","author":"Sussman","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"Fick","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bertrand, V., Massy, N., Vegas, N., Gras, V., Chalouhi, C., Tavolacci, M.-P., and Abadie, V. (2021). Safety of cyproheptadine, an orexigenic drug: Analysis of the French National Pharmacovigilance Database and systematic review. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.712413"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004714-200210000-00012","article-title":"Tolerance to daytime sedative effects of H1 antihistamines","volume":"22","author":"Richardson","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/54\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:47:15Z","timestamp":1766501235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010054"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010054","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}